Inhibition of sympathetic cholinergic vasodilatation by a selective NPY Y2 receptor agonist in the gracilis muscle of anaesthetised dogs

Journal of the Autonomic Nervous System

Volumn 68, Issue 1-2, 1998, Pages 14-20

  Mahns, David A ^a   Revington, Maureen L ^a   Runcie, Myfanwy J ^a   McCloskey, D I ^a   Potter, Erica K ^a  

^a NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

Author keywords

Agonist; Cholinergic vasodilatation; NPY; NPY Y2; Sympathetic vasoconstriction

Indexed keywords

NEUROPEPTIDE Y; NEUROPEPTIDE Y DERIVATIVE; NEUROPEPTIDE Y2 RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; CHOLINERGIC TRANSMISSION; DOG; FEMALE; GRACILIS MUSCLE; MALE; MUSCLE BLOOD FLOW; NERVE ENDING; NEUROMODULATION; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; SYMPATHETIC TONE;

EID: 0032545617     PISSN: 01651838     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-1838(97)00111-2     Document Type: Article

References (31)

1. Ballard D.R., Abboud F.M., Mayer H.E. Release of a humoral vasodilator substance during neurogenic vasodilatation. Am. J. Physiol. 219:1970;1451-1457.
2. Beck L., Pollard A.A., Kayaalp S.O., Weiner L.M. Sustained dilatation elicited by sympathetic nerve stimulation. Fed. Proc. 25:1966;1596-1606.
3. Dahlof C., Dahlof P., Lundberg J.M. Neuropeptide Y (NPY): Enhancement of blood pressure increase upon alpha-adrenoceptor activation and direct pressor effects in pithed rats. Eur. J. Pharm. 109:1985;289-292.
4. Dahlof P., Persson K., Lundberg J.M., Dahlof C. Neuropeptide Y (NPY) induced inhibition of preganglionic nerve stimulation evoked release of adrenalin and noradrenaline in the pithed rat. Acta Physiol. Scand. 132:1988;51-57.
5. Edvinsson L., Ekblad E., Hakanson R., Wahlestedt C. Neuropeptide Y potentiates the effect of various vasoconstrictor agents on rabbit blood vessels. Br. J. Pharm. 83:1984;519-525.
6. Fielden R., Green A.L. A comparative study of the noradrenaline-depleting and sympathetic-blocking actions of guanethidine and (-)-?-hydroxyphenethylguanidine. Br. J. Chemother. 30:1967;155-165.
7. Glover W.E. Increased sensitivity of rabbit ear artery to noradrenaline following perivascular nerve stimulation may be a response to neuropeptide Y released as cotransmitter. Clin. Exp. Pharm. Physiol. 12:1985;227-230.
8. Granger H.J., Goodman A.H., Granger D.N. Role of resistance and exchange vessels in local microvascular control of skeletal muscle oxygenation in the dog. Circ. Res. 38:1976;379-385.
9. 3H ]-noradrenaline Br. J. Pharm. 18:1962;161-166.
10. Kahan T., Pernow J., Schwieler J., Lundberg J.M., Hjemdahl P., Wallin B.G. Involvement of neuropeptide Y in sympathetic vascular control of skeletal muscle in vivo. J. Hyperten. 6:1988;S532-4.
11. Karim F., Ballard H.J., Cotterrell D. Changes in adenosine release and blood flow in the contracting dog gracilis muscle. Pfluegers Arch. Eur. J. Physiol. 412:1988;106-112.
12. Kilborn M.J., Potter E.K., McCloskey D.I. Neuromodulation of the cardiac vagus: Comparison of neuropeptide Y and related peptides. Regul. Pept. 12:1985;155-161.
13. Lacroix J.S., Stjarne P., Anggard A., Lundberg J.M. Sympathetic vascular control of the pig nasal mucosa (2): Reserpine-resistant, non-adrenergic nervous responses in relation to neuropeptide Y and ATP. Acta Physiol. Scand. 133:1988;183-197.
14. 2 prejunctional receptor. Br. J. Pharm. 113:1994;479-484.
15. Lundberg J.M., Hua X.Y., Franco-Cereceda A. Effects of neuropeptide Y (NPY) on mechanical activity and neurotransmission in the heart, vas deferens and urinary bladder of the guinea-pig. Acta Physiol. Scand. 121:1984;325-332.
16. Lundberg J.M., Terenius L., Hokfelt T., Goldstein M. High levels of neuropeptide Y in peripheral noradrenergic neurons in various mammals including man. Neurosci. Lett. 42:1983;167-172.
17. McCloskey D.I., Potter E.K. Neuropeptide Y and cardiovascular regulation. Clin. Exp. Pharm. Physiol. 18:1991;47-49.
18. Modin A., Pernow J., Lundberg J.M. Evidence for two neuropeptide Y receptors mediating vasoconstriction. Eur. J. Pharm. 203:1991;165-171.
19. Modin A., Pernow J., Lundberg J.M. Sympathetic regulation of skeletal muscle blood flow in the pig: A non-adrenergic component likely to be mediated by neuropeptide Y. Acta Physiol. Scand. 148:1993;1-11.
20. Morris J.L., Sabesan S. Comparison of the NPY receptors mediating vasoconstriction of the guinea-pig uterine artery and thoracic vena cava using a range of NPY analogues. Neuropeptides. 26:1994;21-28.
21. Pernow J., Kahan T., Hjemdahl P., Lundberg J.M. Possible involvement of neuropeptide Y in sympathetic vascular control of canine skeletal muscle. Acta Physiol. Scand. 132:1988;43-50.
22. Potter E.K. Prolonged non-adrenergic inhibition of cardiac vagal action following sympathetic stimulation: Neuromodulation by neuropeptide Y? Neurosci. Lett. 54:1985;117-121.
23. Potter E.K. Guanethidine blocks neuropeptide-Y-like inhibitory action of sympathetic nerves on cardiac vagus. J. Auton. Nerv. Sys. 21:1987;87-90.
24. Potter E.K. Presynaptic inhibition of cardiac vagal postganglionic nerves by neuropeptide Y. Neurosci. Lett. 83:1987;101-106. abstract.
25. 2) receptor. Eur. J. Pharm. 267:1994;253-262.
26. Potter E.K., Mitchell L., McCloskey M.J., Tseng A., Goodman A.E., Shine J., McCloskey D.I. Pre- and postjunctional actions of neuropeptide Y and related peptides. Regul. Pept. 25:1989;167-177.
27. Revington M.L., McCloskey D.I. Neuropeptide Y and control of vascular resistance in skeletal muscle. Regul. Pept. 23:1988;331-342.
28. Uvnas B. Cholinergic vasodilator nerves. Fed. Proc. 25:1966;1618-1622.
29. Wahlestedt C., Yanaihara N., Hakanson R. Evidence for different pre-and post-junctional receptors for neuropeptide Y and related peptides. Regul. Pept. 13:1986;307-318.
30. J.H. Zar, Biostatistical Analysis, Prentice-Hall, Englewood Cliffs, 1984.
31. Zukowska-Grojec Z., Haass M., Bayorh M.A. Neuropeptide Y and peptide YY mediate nonadrenergic vasoconstriction and modulate sympathetic responses in rats. Regul. Pept. 15:1986;99-110.